Opus Genetics, Inc. (IRD)

CIK 1228627 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Opus Genetics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 202640001140361-26-036347
Sep 11, 20268-K0001140361-26-036277
Sep 9, 20268-K0001140361-26-035979
Sep 8, 202640001140361-26-035913
Sep 8, 202640001140361-26-035912
Sep 3, 20261440001974158-26-000100
Aug 14, 2026SCHEDULE 13G/A0001727492-26-000020
Aug 14, 2026EFFECT9999999995-26-002668
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003425
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352641
Aug 7, 2026S-30001140361-26-031740
Aug 6, 20268-K0001628280-26-053824
Aug 6, 202610-Q0001628280-26-054381
Jul 27, 202640000905148-26-003351
Jul 27, 202640000905148-26-003352
Jul 27, 202640000905148-26-003353
Jul 27, 202640000905148-26-003354
Jul 23, 20261440001974078-26-000274
Jul 23, 20261440001974078-26-000273
Jul 23, 20261440001974158-26-000090
Jul 23, 20261440001974158-26-000091
Jun 17, 2026424B20001140361-26-025525
Jun 16, 20268-K0001140361-26-025440
Jun 16, 20268-K0001140361-26-025363
Jun 15, 2026EFFECT9999999995-26-002021